Skip to main content
Erschienen in: Heart Failure Reviews 1/2020

18.10.2019

Congestion occurrence and evaluation in acute heart failure scenario: time to reconsider different pathways of volume overload

verfasst von: Alberto Palazzuoli, Isabella Evangelista, Ranuccio Nuti

Erschienen in: Heart Failure Reviews | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Although congestion is considered to be the main reason for hospital admission in patients with acute heart failure, a simplistic view considering idro saline retention and total body volume accumulation did not provide convincing data. Clinical congestion occurrence is often the tip of the iceberg of several different mechanisms ranging from increased filling pressure to extravascular fluid accumulation and blood flow redistribution. Therefore, the clinical evaluation is often restricted to a simple physical examination including few and inaccurate signs and symptoms. This superficial approach has led to contradictory data and patients have not been evaluated according to a more realistic clinical scenario. The integration with new diagnostic ultrasonographic and laboratory tools would substantially improve these weaknesses. Indeed, congestion could be assessed by following the most recognized HF subtypes including primitive cardiac defect, presence of right ventricular dysfunction, and organ perfusion. Moreover, there is a tremendous gap regarding the interchangeable concept of fluid retention and redistribution used with a univocal meaning. Overall, congestion assessment should be revised, considering it as either central, peripheral, or both. In this review, we aim to provide different evidence regarding the concept of congestion starting from the most recognized pathophysiological mechanisms of AHF decompensation. We highlight the fact that a better knowledge of congestion is a challenge for future investigation and it could lead to significant advances in HF treatment.
Literatur
1.
Zurück zum Zitat Gheorghiade M, Filippatos G, De Luca I, Burnett J (2006) Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 119:S3–S10CrossRefPubMed Gheorghiade M, Filippatos G, De Luca I, Burnett J (2006) Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 119:S3–S10CrossRefPubMed
2.
Zurück zum Zitat O’Connor CM, Stough WG, Gallup DS, Husselblad V, Gheorghiade M (2005) Demographic clinical characteristics and outcome of patients hospitalized for decompensated heart failure: observation from the IMPACT-HF registry. J Card Fail 11:200–205CrossRefPubMed O’Connor CM, Stough WG, Gallup DS, Husselblad V, Gheorghiade M (2005) Demographic clinical characteristics and outcome of patients hospitalized for decompensated heart failure: observation from the IMPACT-HF registry. J Card Fail 11:200–205CrossRefPubMed
3.
Zurück zum Zitat Pang P, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M, Acute Heart Failure Syndromes International Working Group (2008) A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 29:816–824CrossRefPubMed Pang P, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M, Acute Heart Failure Syndromes International Working Group (2008) A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 29:816–824CrossRefPubMed
5.
Zurück zum Zitat Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12:423–433. https://doi.org/10.1093/eurjhf/hfq045 CrossRefPubMed Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12:423–433. https://​doi.​org/​10.​1093/​eurjhf/​hfq045 CrossRefPubMed
7.
Zurück zum Zitat Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C, Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators (2004) Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291:1963–1971CrossRefPubMed Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C, Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators (2004) Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291:1963–1971CrossRefPubMed
8.
Zurück zum Zitat Metra M, O'Connor CM, Davison BA, Cleland JG, Ponikowski P, Teerlink JR, Voors AA, Givertz MM, Mansoor GA, Bloomfield DM, Jia G, DeLucca P, Massie B, Dittrich H, Cotter G (2011) Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT study. Eur Heart J 32:1519–1534. https://doi.org/10.1093/eurheartj/ehr042 CrossRefPubMed Metra M, O'Connor CM, Davison BA, Cleland JG, Ponikowski P, Teerlink JR, Voors AA, Givertz MM, Mansoor GA, Bloomfield DM, Jia G, DeLucca P, Massie B, Dittrich H, Cotter G (2011) Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT study. Eur Heart J 32:1519–1534. https://​doi.​org/​10.​1093/​eurheartj/​ehr042 CrossRefPubMed
9.
Zurück zum Zitat Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, Maggioni AP, Swedberg K, Konstam MA, Zannad F, Gheorghiade M (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14:302–311. https://doi.org/10.1093/eurjhf/hfs007 CrossRefPubMed Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, Maggioni AP, Swedberg K, Konstam MA, Zannad F, Gheorghiade M (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14:302–311. https://​doi.​org/​10.​1093/​eurjhf/​hfs007 CrossRefPubMed
10.
Zurück zum Zitat Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors A, Nielsen OW, Zannad F, Tavazzi L (2010) EURObservational research Programme: the heart failure pilot survey (ESC-HF pilot). Eur J Heart Fail 12:1076–1084. https://doi.org/10.1093/eurjhf/hfq154 CrossRefPubMed Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors A, Nielsen OW, Zannad F, Tavazzi L (2010) EURObservational research Programme: the heart failure pilot survey (ESC-HF pilot). Eur J Heart Fail 12:1076–1084. https://​doi.​org/​10.​1093/​eurjhf/​hfq154 CrossRefPubMed
11.
Zurück zum Zitat Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Pérez-Calvo JI, Voors AA (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 258:185–191. https://doi.org/10.1016/j.ijcard.2018.01.067 CrossRefPubMed Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Pérez-Calvo JI, Voors AA (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 258:185–191. https://​doi.​org/​10.​1016/​j.​ijcard.​2018.​01.​067 CrossRefPubMed
12.
Zurück zum Zitat Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, DeVore AD, Khazanie P, Redfield MM, Goldsmith SR, Bart BA, Anstrom KJ, Felker GM, Hernandez AF, Stevenson LW (2015) Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail 8:741–748. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001957 CrossRefPubMedPubMedCentral Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, DeVore AD, Khazanie P, Redfield MM, Goldsmith SR, Bart BA, Anstrom KJ, Felker GM, Hernandez AF, Stevenson LW (2015) Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail 8:741–748. https://​doi.​org/​10.​1161/​CIRCHEARTFAILURE​.​114.​001957 CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Galas A, Krzesiński P, Gielerak G, Piechota W, Uziębło-Życzkowska B, Stańczyk A, Piotrowicz K, Banak M (2018) Complex assessment of patients with decompensated heart failure: the clinical value of impedance cardiography and N-terminal pro-brain natriuretic peptide. Heart Lung S0147-9563(18):30290–30295. https://doi.org/10.1016/j.hrtlng.2018.10.004 CrossRef Galas A, Krzesiński P, Gielerak G, Piechota W, Uziębło-Życzkowska B, Stańczyk A, Piotrowicz K, Banak M (2018) Complex assessment of patients with decompensated heart failure: the clinical value of impedance cardiography and N-terminal pro-brain natriuretic peptide. Heart Lung S0147-9563(18):30290–30295. https://​doi.​org/​10.​1016/​j.​hrtlng.​2018.​10.​004 CrossRef
16.
18.
Zurück zum Zitat Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, Testani JM, Tang WHW, Orso F, Rossignol P, Metra M, Filippatos G, Seferovic PM, Ruschitzka F, Coats AJ (2019) The use of diuretics in heart failure with congestion - a position statement from the heart failure Association of the European Society of cardiology. Eur J Heart Fail 21:137–155. https://doi.org/10.1002/ejhf.1369 CrossRefPubMed Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, Testani JM, Tang WHW, Orso F, Rossignol P, Metra M, Filippatos G, Seferovic PM, Ruschitzka F, Coats AJ (2019) The use of diuretics in heart failure with congestion - a position statement from the heart failure Association of the European Society of cardiology. Eur J Heart Fail 21:137–155. https://​doi.​org/​10.​1002/​ejhf.​1369 CrossRefPubMed
20.
Zurück zum Zitat Mahdyoon H, Klein R, Eyler W, Lakier JB, Chakko SC, Gheorghiade M (1989) Radiographic pulmonary congestion in end-stage congestive heart failure. Am J Cardiol 63:625–627CrossRefPubMed Mahdyoon H, Klein R, Eyler W, Lakier JB, Chakko SC, Gheorghiade M (1989) Radiographic pulmonary congestion in end-stage congestive heart failure. Am J Cardiol 63:625–627CrossRefPubMed
21.
Zurück zum Zitat Collins SP, Lindsell CJ, Storrow AB, Abraham WT, ADHERE Scientific Advisory Committee, Investigators and Study Group (2006) Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med 47:13–18CrossRefPubMed Collins SP, Lindsell CJ, Storrow AB, Abraham WT, ADHERE Scientific Advisory Committee, Investigators and Study Group (2006) Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med 47:13–18CrossRefPubMed
22.
Zurück zum Zitat Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 294:1625–1633CrossRefPubMed Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 294:1625–1633CrossRefPubMed
23.
Zurück zum Zitat Ambrosy AP, Cerbin LP, Armstrong PW, Butler J, Coles A, DeVore AD, Dunlap ME, Ezekowitz JA, Felker GM, Fudim M, Greene SJ, Hernandez AF, O'Connor CM, Schulte P, Starling RC, Teerlink JR, Voors AA, Mentz R (2017) Body weight change during and after hospitalization for acute heart failure: patient characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. JACC Heart Fail 5:1–13. https://doi.org/10.1016/j.jchf.2016.09.012 CrossRefPubMedPubMedCentral Ambrosy AP, Cerbin LP, Armstrong PW, Butler J, Coles A, DeVore AD, Dunlap ME, Ezekowitz JA, Felker GM, Fudim M, Greene SJ, Hernandez AF, O'Connor CM, Schulte P, Starling RC, Teerlink JR, Voors AA, Mentz R (2017) Body weight change during and after hospitalization for acute heart failure: patient characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. JACC Heart Fail 5:1–13. https://​doi.​org/​10.​1016/​j.​jchf.​2016.​09.​012 CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner W, Filippatos GS, Flammer AJ, Fuhrmann V, Lainscak M, Lassus J, Legrand M, Masip J, Mueller C, Papp Z, Parissis J, Platz E, Rudiger A, Ruschitzka F, Schäfer A, Seferovic PM, Skouri H, Yilmaz MB, Mebazaa A (2017) Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the acute heart failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 19:821–836. https://doi.org/10.1002/ejhf.872 CrossRefPubMed Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner W, Filippatos GS, Flammer AJ, Fuhrmann V, Lainscak M, Lassus J, Legrand M, Masip J, Mueller C, Papp Z, Parissis J, Platz E, Rudiger A, Ruschitzka F, Schäfer A, Seferovic PM, Skouri H, Yilmaz MB, Mebazaa A (2017) Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the acute heart failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 19:821–836. https://​doi.​org/​10.​1002/​ejhf.​872 CrossRefPubMed
26.
Zurück zum Zitat Filippatos G, Zannad F (2007) An introduction to acute heart failure syndromes: definition and classification. Heart Fail Rev 12:87–90CrossRefPubMed Filippatos G, Zannad F (2007) An introduction to acute heart failure syndromes: definition and classification. Heart Fail Rev 12:87–90CrossRefPubMed
27.
Zurück zum Zitat Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, Laroche C, Seferovic PM, Anker SD, Ferrari R, Ruschitzka F, Lopez-Fernandez S, Miani D, Filippatos G, Maggioni AP (2017) Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC heart failure long-term registry. Eur J Heart Fail 19:1242–1254. https://doi.org/10.1002/ejhf.890 CrossRefPubMed Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, Laroche C, Seferovic PM, Anker SD, Ferrari R, Ruschitzka F, Lopez-Fernandez S, Miani D, Filippatos G, Maggioni AP (2017) Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC heart failure long-term registry. Eur J Heart Fail 19:1242–1254. https://​doi.​org/​10.​1002/​ejhf.​890 CrossRefPubMed
31.
Zurück zum Zitat Van Aelst LNL, Arrigo M, Placido R, Akiyama E, Girerd N, Zannad F, Manivet P, Rossignol P, Badoz M, Sadoune M, Launay JM, Gayat E, Lam CSP, Cohen-Solal A, Mebazaa A, Seronde MF (2018) Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion. Eur J Heart Fail 20:738–747. https://doi.org/10.1002/ejhf.1050 CrossRefPubMed Van Aelst LNL, Arrigo M, Placido R, Akiyama E, Girerd N, Zannad F, Manivet P, Rossignol P, Badoz M, Sadoune M, Launay JM, Gayat E, Lam CSP, Cohen-Solal A, Mebazaa A, Seronde MF (2018) Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion. Eur J Heart Fail 20:738–747. https://​doi.​org/​10.​1002/​ejhf.​1050 CrossRefPubMed
32.
Zurück zum Zitat De Luca L, Fonarow GC, Adams KF Jr, Mebazaa A, Tavazzi L, Swedberg K, Gheorghiade M (2007) Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy. Heart Fail Rev 12:97–104CrossRefPubMed De Luca L, Fonarow GC, Adams KF Jr, Mebazaa A, Tavazzi L, Swedberg K, Gheorghiade M (2007) Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy. Heart Fail Rev 12:97–104CrossRefPubMed
35.
Zurück zum Zitat Tromp J, Khan MAF, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, Van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P (2017) Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC Heart Fail 5:507–517. https://doi.org/10.1016/j.jchf.2017.04.007 CrossRefPubMed Tromp J, Khan MAF, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, Van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P (2017) Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC Heart Fail 5:507–517. https://​doi.​org/​10.​1016/​j.​jchf.​2017.​04.​007 CrossRefPubMed
36.
Zurück zum Zitat Tromp J, Westenbrink BD, Ouwerkerk W, van Veldhuisen DJ, Samani NJ, Ponikowski P, Metra M, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Lang CC, Ng LL, Zannad F, Zwinderman AH, Hillege HL, van der Meer P, Voors AA (2018) Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 72:1081–1090. https://doi.org/10.1016/j.jacc.2018.06.050 CrossRefPubMed Tromp J, Westenbrink BD, Ouwerkerk W, van Veldhuisen DJ, Samani NJ, Ponikowski P, Metra M, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Lang CC, Ng LL, Zannad F, Zwinderman AH, Hillege HL, van der Meer P, Voors AA (2018) Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 72:1081–1090. https://​doi.​org/​10.​1016/​j.​jacc.​2018.​06.​050 CrossRefPubMed
38.
Zurück zum Zitat Balmain S, Padmanabhan N, Ferrell WR, Morton JJ, McMurray JJ (2007) Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. Eur J Heart Fail 9:865–871CrossRefPubMed Balmain S, Padmanabhan N, Ferrell WR, Morton JJ, McMurray JJ (2007) Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. Eur J Heart Fail 9:865–871CrossRefPubMed
44.
Zurück zum Zitat Ghio S, Guazzi M, Scardovi AB, Klersy C, Clemenza F, Carluccio E, Temporelli PL, Rossi A, Faggiano P, Traversi E, Vriz O, Dini FL (2017) Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. Eur J Heart Fail 19:873–879. https://doi.org/10.1002/ejhf.664 CrossRefPubMed Ghio S, Guazzi M, Scardovi AB, Klersy C, Clemenza F, Carluccio E, Temporelli PL, Rossi A, Faggiano P, Traversi E, Vriz O, Dini FL (2017) Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. Eur J Heart Fail 19:873–879. https://​doi.​org/​10.​1002/​ejhf.​664 CrossRefPubMed
46.
Zurück zum Zitat Cotter G, Felker MG, Kirkwood AF, Milo-Cotter O, O’Connor CM (2008) The pathophysiology of acute heart failure. It is all about fluid accumulation? Am Heart J 155:9–18CrossRefPubMed Cotter G, Felker MG, Kirkwood AF, Milo-Cotter O, O’Connor CM (2008) The pathophysiology of acute heart failure. It is all about fluid accumulation? Am Heart J 155:9–18CrossRefPubMed
48.
Zurück zum Zitat Vagnarelli F, Corsini A, Lorenzini M, Pacini D, Ferlito M, Bacchi Reggiani L, Longhi S, Nanni S, Norscini G, Cinti L, Bugani G, Pasquale F, Biagini E, Grigioni F, Di Bartolomeo R, Marini M, Perna GP, Melandri G, Rapezzi C (2015) Acute heart failure in patients with acute aortic syndrome: pathophysiology and clinical-prognostic implications. Eur J Heart Fail 17:917–924. https://doi.org/10.1002/ejhf.325 CrossRefPubMed Vagnarelli F, Corsini A, Lorenzini M, Pacini D, Ferlito M, Bacchi Reggiani L, Longhi S, Nanni S, Norscini G, Cinti L, Bugani G, Pasquale F, Biagini E, Grigioni F, Di Bartolomeo R, Marini M, Perna GP, Melandri G, Rapezzi C (2015) Acute heart failure in patients with acute aortic syndrome: pathophysiology and clinical-prognostic implications. Eur J Heart Fail 17:917–924. https://​doi.​org/​10.​1002/​ejhf.​325 CrossRefPubMed
51.
Zurück zum Zitat Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM (2013) Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 62:D22–D33CrossRefPubMed Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM (2013) Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 62:D22–D33CrossRefPubMed
52.
Zurück zum Zitat Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA (2014) Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35:3452–3462CrossRefPubMedPubMedCentral Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA (2014) Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35:3452–3462CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB, National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure (2006) Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 114:1883–1891CrossRefPubMed Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB, National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure (2006) Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 114:1883–1891CrossRefPubMed
55.
Zurück zum Zitat Brewster UC, Setaro JF, Perazella MA (2003) The renin angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 326:15–24CrossRefPubMed Brewster UC, Setaro JF, Perazella MA (2003) The renin angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 326:15–24CrossRefPubMed
56.
Zurück zum Zitat Sinkeler SJ, Damman K, van Veldhuisen DJ, Hillege H, Navis G (2012) A reappraisal of volume status and renal function impairment in chronic heart failure: combined effect of pre renal failure and venous congestion on renal function. Heart Fail Rev 17:263–270CrossRefPubMed Sinkeler SJ, Damman K, van Veldhuisen DJ, Hillege H, Navis G (2012) A reappraisal of volume status and renal function impairment in chronic heart failure: combined effect of pre renal failure and venous congestion on renal function. Heart Fail Rev 17:263–270CrossRefPubMed
58.
Zurück zum Zitat Birch DJ, Turmaine M, Boulos PB, Burnstock G (2008) Sympathetic innervation of human mesenteric artery and vein. J Vasc Res 45:323–332CrossRefPubMed Birch DJ, Turmaine M, Boulos PB, Burnstock G (2008) Sympathetic innervation of human mesenteric artery and vein. J Vasc Res 45:323–332CrossRefPubMed
60.
Zurück zum Zitat Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274CrossRefPubMed Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274CrossRefPubMed
61.
Zurück zum Zitat Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5:54–62CrossRefPubMed Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5:54–62CrossRefPubMed
62.
Zurück zum Zitat Miller WL, Mullan BP (2014) Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation. JACC Heart Fail 2:298–305CrossRefPubMed Miller WL, Mullan BP (2014) Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation. JACC Heart Fail 2:298–305CrossRefPubMed
67.
Zurück zum Zitat Tarbell JM, Pahakis MY (2006) Mechano transduction and the glycocalyx. J Intern Med 259:339–350CrossRefPubMed Tarbell JM, Pahakis MY (2006) Mechano transduction and the glycocalyx. J Intern Med 259:339–350CrossRefPubMed
68.
Zurück zum Zitat Oberleithner H, Peters W, Kusche-Vihrog K, Korte S, Schillers H, Kliche K, Oberleithner K (2011) Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch 462:519–528CrossRefPubMedPubMedCentral Oberleithner H, Peters W, Kusche-Vihrog K, Korte S, Schillers H, Kliche K, Oberleithner K (2011) Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch 462:519–528CrossRefPubMedPubMedCentral
69.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16(2015):233–270CrossRefPubMed Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16(2015):233–270CrossRefPubMed
70.
Zurück zum Zitat Mercurio V, Palazzuoli A, Correale M, Lombardi C, Passantino A, Ravera A, Ruocco G, Sciatti E, Triggiani M, Lagioia R, Scrutinio D, Tocchetti CG, Nodari S (2018) Right heart dysfunction: from pathophysiologic insights to therapeutic options: a translational overview. J Cardiovasc Med (Hagerstown) 19:613–623. https://doi.org/10.2459/JCM.0000000000000700 CrossRef Mercurio V, Palazzuoli A, Correale M, Lombardi C, Passantino A, Ravera A, Ruocco G, Sciatti E, Triggiani M, Lagioia R, Scrutinio D, Tocchetti CG, Nodari S (2018) Right heart dysfunction: from pathophysiologic insights to therapeutic options: a translational overview. J Cardiovasc Med (Hagerstown) 19:613–623. https://​doi.​org/​10.​2459/​JCM.​0000000000000700​ CrossRef
71.
Zurück zum Zitat Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ et al (2013) Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 62(25 Suppl):D22–D33CrossRefPubMed Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ et al (2013) Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 62(25 Suppl):D22–D33CrossRefPubMed
72.
Zurück zum Zitat Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ (2003) A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41(6):1021–1027CrossRefPubMed Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ (2003) A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41(6):1021–1027CrossRefPubMed
73.
Zurück zum Zitat Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E (2008) Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail 10:70–77CrossRefPubMed Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E (2008) Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail 10:70–77CrossRefPubMed
74.
Zurück zum Zitat Platz E, Lewis EF, Uno H, Peck J, Pivetta E, Merz AA, Hempel D, Wilson C, Frasure SE, Jhund PS, Cheng S, Solomon SD (2016) Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. Eur Heart J 37:1244–1251CrossRefPubMedPubMedCentral Platz E, Lewis EF, Uno H, Peck J, Pivetta E, Merz AA, Hempel D, Wilson C, Frasure SE, Jhund PS, Cheng S, Solomon SD (2016) Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. Eur Heart J 37:1244–1251CrossRefPubMedPubMedCentral
75.
Zurück zum Zitat Cogliati C, Casazza G, Ceriani E, Torzillo D, Furlotti S, Bossi I, Vago T, Costantino G, Montano N (2016) Lung ultrasound and short-term prognosis in heart failure patients. Int J Cardiol 218:104–108CrossRefPubMed Cogliati C, Casazza G, Ceriani E, Torzillo D, Furlotti S, Bossi I, Vago T, Costantino G, Montano N (2016) Lung ultrasound and short-term prognosis in heart failure patients. Int J Cardiol 218:104–108CrossRefPubMed
76.
Zurück zum Zitat Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N (2015) Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17:1172–1181CrossRefPubMed Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N (2015) Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17:1172–1181CrossRefPubMed
77.
Zurück zum Zitat Jambrik Z, Monti S, Coppola V, Agricola E, Mottola G, Miniati M, Picano E (2004) Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol 93:1265–1270CrossRefPubMed Jambrik Z, Monti S, Coppola V, Agricola E, Mottola G, Miniati M, Picano E (2004) Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol 93:1265–1270CrossRefPubMed
78.
Zurück zum Zitat Mueller T, Gegenhuber A, Poelz W, Haltmayer M (2005) Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart. 91:606–612CrossRefPubMedPubMedCentral Mueller T, Gegenhuber A, Poelz W, Haltmayer M (2005) Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart. 91:606–612CrossRefPubMedPubMedCentral
80.
Zurück zum Zitat Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S, Ianuzzi J (2006)NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP investigation of Dyspnoea in the emergency department (PRIDE) echocardiographic substudy. Eur Heart J 27:839–845CrossRefPubMed Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S, Ianuzzi J (2006)NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP investigation of Dyspnoea in the emergency department (PRIDE) echocardiographic substudy. Eur Heart J 27:839–845CrossRefPubMed
82.
Zurück zum Zitat Savarese G, Musella F, D'Amore C, Vassallo E, Losco T, Gambardella F, Cecere M, Petraglia L, Pagano G, Fimiani L, Rengo G, Leosco D, Trimarco B, Perrone-Filardi P (2014) Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. JACC Heart Fail 2:148–158. https://doi.org/10.1016/j.jchf.2013.11.007 CrossRefPubMed Savarese G, Musella F, D'Amore C, Vassallo E, Losco T, Gambardella F, Cecere M, Petraglia L, Pagano G, Fimiani L, Rengo G, Leosco D, Trimarco B, Perrone-Filardi P (2014) Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. JACC Heart Fail 2:148–158. https://​doi.​org/​10.​1016/​j.​jchf.​2013.​11.​007 CrossRefPubMed
84.
Zurück zum Zitat Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP (2014)Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Circ Heart Fail 7:131–139. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000527 CrossRefPubMed Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP (2014)Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Circ Heart Fail 7:131–139. https://​doi.​org/​10.​1161/​CIRCHEARTFAILURE​.​113.​000527 CrossRefPubMed
85.
Zurück zum Zitat Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL Jr, Mark DB, Piña IL, Passmore G, Whellan DJ, Yang H, Cooper LS, Leifer ES, Desvigne-Nickens P, O'Connor CM (2017) Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 318:713–720. https://doi.org/10.1001/jama.2017.10565 CrossRefPubMedPubMedCentral Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL Jr, Mark DB, Piña IL, Passmore G, Whellan DJ, Yang H, Cooper LS, Leifer ES, Desvigne-Nickens P, O'Connor CM (2017) Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 318:713–720. https://​doi.​org/​10.​1001/​jama.​2017.​10565 CrossRefPubMedPubMedCentral
86.
Zurück zum Zitat Kubánek M, Goode KM, Lánská V, Clark AL, Cleland JG (2009) The prognostic value of repeated measurement of N-terminalpro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 11:367–377CrossRefPubMed Kubánek M, Goode KM, Lánská V, Clark AL, Cleland JG (2009) The prognostic value of repeated measurement of N-terminalpro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 11:367–377CrossRefPubMed
87.
Zurück zum Zitat Gaggin HK, Truong QA, Rehman SU, Mohammed AA, Bhardwaj A, Parks KA, Sullivan DA, Chen-Tournoux A, Moore SA, Richards AM, Troughton RW, Lainchbury JG, Weiner RB, Baggish AL, Semigran MJ, Januzzi JL (2013) Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Congest Heart Fail 19:135–142CrossRefPubMed Gaggin HK, Truong QA, Rehman SU, Mohammed AA, Bhardwaj A, Parks KA, Sullivan DA, Chen-Tournoux A, Moore SA, Richards AM, Troughton RW, Lainchbury JG, Weiner RB, Baggish AL, Semigran MJ, Januzzi JL (2013) Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Congest Heart Fail 19:135–142CrossRefPubMed
89.
Zurück zum Zitat Morbach C, Marx A, Kaspar M, Güder G, Brenner S, Feldmann C, Störk S, Vollert JO, Ertl G, Angermann CE (2017) Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides. Eur J Heart Fail 19:1166–1175. https://doi.org/10.1002/ejhf.859 CrossRefPubMed Morbach C, Marx A, Kaspar M, Güder G, Brenner S, Feldmann C, Störk S, Vollert JO, Ertl G, Angermann CE (2017) Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides. Eur J Heart Fail 19:1166–1175. https://​doi.​org/​10.​1002/​ejhf.​859 CrossRefPubMed
92.
Zurück zum Zitat Greene SJ, Gheorghiade M, Vaduganathan M, Ambrosy AP, Mentz RJ, Subacius H, Maggioni AP, Nodari S, Konstam MA, Butler J, Filippatos G (2013) Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 15:1401–1411. https://doi.org/10.1093/eurjhf/hft110 CrossRefPubMedPubMedCentral Greene SJ, Gheorghiade M, Vaduganathan M, Ambrosy AP, Mentz RJ, Subacius H, Maggioni AP, Nodari S, Konstam MA, Butler J, Filippatos G (2013) Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 15:1401–1411. https://​doi.​org/​10.​1093/​eurjhf/​hft110 CrossRefPubMedPubMedCentral
93.
Zurück zum Zitat van der Meer P, Postmus D, Ponikowski P, Cleland JG, O'Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA (2013) The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 61:1973–1981. https://doi.org/10.1016/j.jacc.2012.12.050 CrossRefPubMed van der Meer P, Postmus D, Ponikowski P, Cleland JG, O'Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA (2013) The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 61:1973–1981. https://​doi.​org/​10.​1016/​j.​jacc.​2012.​12.​050 CrossRefPubMed
94.
Zurück zum Zitat Breidthardt T, Weidmann ZM, Twerenbold R, Gantenbein C, Stallone F, Rentsch K, Rubini Gimenez M, Kozhuharov N, Sabti Z, Breitenbücher D, Wildi K, Puelacher C, Honegger U, Wagener M, Schumacher C, Hillinger P, Osswald S, Mueller C (2017) Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function. Eur J Heart Fail 19:226–236. https://doi.org/10.1002/ejhf.667 CrossRefPubMed Breidthardt T, Weidmann ZM, Twerenbold R, Gantenbein C, Stallone F, Rentsch K, Rubini Gimenez M, Kozhuharov N, Sabti Z, Breitenbücher D, Wildi K, Puelacher C, Honegger U, Wagener M, Schumacher C, Hillinger P, Osswald S, Mueller C (2017) Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function. Eur J Heart Fail 19:226–236. https://​doi.​org/​10.​1002/​ejhf.​667 CrossRefPubMed
96.
Zurück zum Zitat Núñez J, Núñez E, Bayés-Genís A, Fonarow GC, Miñana G, Bodí V, Pascual-Figal D, Santas E, Garcia-Blas S, Chorro FJ, Rizopoulos D, Sanchis J (2017)Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure. Eur Heart J Acute Cardiovasc Care 6:685–696. https://doi.org/10.1177/2048872616649757 CrossRefPubMed Núñez J, Núñez E, Bayés-Genís A, Fonarow GC, Miñana G, Bodí V, Pascual-Figal D, Santas E, Garcia-Blas S, Chorro FJ, Rizopoulos D, Sanchis J (2017)Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure. Eur Heart J Acute Cardiovasc Care 6:685–696. https://​doi.​org/​10.​1177/​2048872616649757​ CrossRefPubMed
Metadaten
Titel
Congestion occurrence and evaluation in acute heart failure scenario: time to reconsider different pathways of volume overload
verfasst von
Alberto Palazzuoli
Isabella Evangelista
Ranuccio Nuti
Publikationsdatum
18.10.2019
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 1/2020
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-019-09868-0

Weitere Artikel der Ausgabe 1/2020

Heart Failure Reviews 1/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.